rs8112073
Variant names:
Your query was ambiguous. Multiple possible variants found:
Variant summary
Our verdict is Benign. The variant received -12 ACMG points: 0P and 12B. BP4_StrongBS1BS2
The NM_001316994.2(SPACA6):c.92-1965G>A variant causes a intron change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.00383 in 434,878 control chromosomes in the GnomAD database, including 18 homozygotes. In-silico tool predicts a benign outcome for this variant. No clinical diagnostic laboratories have submitted clinical-significance assessments for this variant to ClinVar.
Frequency
Genomes: 𝑓 0.0091 ( 15 hom., cov: 32)
Exomes 𝑓: 0.0010 ( 3 hom. )
Consequence
SPACA6
NM_001316994.2 intron
NM_001316994.2 intron
Scores
2
Clinical Significance
Not reported in ClinVar
Conservation
PhyloP100: 1.57
Publications
2 publications found
Genes affected
SPACA6 (HGNC:27113): (sperm acrosome associated 6) Predicted to be involved in fusion of sperm to egg plasma membrane involved in single fertilization. Predicted to be located in acrosomal vesicle. [provided by Alliance of Genome Resources, Apr 2022]
SPACA6-AS1 (HGNC:49383): (SPACA6 antisense RNA 1)
MIR99B (HGNC:31651): (microRNA 99b) microRNAs (miRNAs) are short (20-24 nt) non-coding RNAs that are involved in post-transcriptional regulation of gene expression in multicellular organisms by affecting both the stability and translation of mRNAs. miRNAs are transcribed by RNA polymerase II as part of capped and polyadenylated primary transcripts (pri-miRNAs) that can be either protein-coding or non-coding. The primary transcript is cleaved by the Drosha ribonuclease III enzyme to produce an approximately 70-nt stem-loop precursor miRNA (pre-miRNA), which is further cleaved by the cytoplasmic Dicer ribonuclease to generate the mature miRNA and antisense miRNA star (miRNA*) products. The mature miRNA is incorporated into a RNA-induced silencing complex (RISC), which recognizes target mRNAs through imperfect base pairing with the miRNA and most commonly results in translational inhibition or destabilization of the target mRNA. The RefSeq represents the predicted microRNA stem-loop. [provided by RefSeq, Sep 2009]
Genome browser will be placed here
ACMG classification
Classification was made for transcript
Our verdict: Benign. The variant received -12 ACMG points.
BP4
Computational evidence support a benign effect (BayesDel_noAF=-0.81).
BS1
Variant frequency is greater than expected in population afr. GnomAd4 allele frequency = 0.00911 (1385/152064) while in subpopulation AFR AF = 0.0312 (1295/41484). AF 95% confidence interval is 0.0298. There are 15 homozygotes in GnomAd4. There are 637 alleles in the male GnomAd4 subpopulation. Median coverage is 32. This position passed quality control check.
BS2
High Homozygotes in GnomAd4 at 15 gene
Transcripts
RefSeq
Ensembl
| Gene | Transcript | HGVSc | HGVSp | Effect | Exon rank | TSL | MANE | Protein | Appris | UniProt |
|---|---|---|---|---|---|---|---|---|---|---|
| SPACA6 | ENST00000710615.1 | c.-41-1965G>A | intron_variant | Intron 1 of 8 | ENSP00000518379.1 | |||||
| SPACA6 | ENST00000646845.1 | c.368-1965G>A | intron_variant | Intron 1 of 1 | ENSP00000496692.1 | |||||
| SPACA6-AS1 | ENST00000602324.1 | n.823+121C>T | intron_variant | Intron 1 of 1 | 2 | |||||
| MIR99B | ENST00000384819.1 | n.-99G>A | upstream_gene_variant | 6 |
Frequencies
GnomAD3 genomes AF: 0.00904 AC: 1374AN: 151946Hom.: 13 Cov.: 32 show subpopulations
GnomAD3 genomes
AF:
AC:
1374
AN:
151946
Hom.:
Cov.:
32
Gnomad AFR
AF:
Gnomad AMI
AF:
Gnomad AMR
AF:
Gnomad ASJ
AF:
Gnomad EAS
AF:
Gnomad SAS
AF:
Gnomad FIN
AF:
Gnomad MID
AF:
Gnomad NFE
AF:
Gnomad OTH
AF:
GnomAD4 exome AF: 0.000997 AC: 282AN: 282814Hom.: 3 AF XY: 0.000837 AC XY: 136AN XY: 162536 show subpopulations
GnomAD4 exome
AF:
AC:
282
AN:
282814
Hom.:
AF XY:
AC XY:
136
AN XY:
162536
show subpopulations
African (AFR)
AF:
AC:
189
AN:
6200
American (AMR)
AF:
AC:
39
AN:
15016
Ashkenazi Jewish (ASJ)
AF:
AC:
0
AN:
8360
East Asian (EAS)
AF:
AC:
0
AN:
9764
South Asian (SAS)
AF:
AC:
4
AN:
53938
European-Finnish (FIN)
AF:
AC:
0
AN:
24252
Middle Eastern (MID)
AF:
AC:
3
AN:
972
European-Non Finnish (NFE)
AF:
AC:
19
AN:
151808
Other (OTH)
AF:
AC:
28
AN:
12504
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.523
Heterozygous variant carriers
0
14
29
43
58
72
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance
Age Distribution
Exome Het
Exome Hom
Variant carriers
0
10
20
30
40
50
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
GnomAD4 genome AF: 0.00911 AC: 1385AN: 152064Hom.: 15 Cov.: 32 AF XY: 0.00857 AC XY: 637AN XY: 74342 show subpopulations
GnomAD4 genome
AF:
AC:
1385
AN:
152064
Hom.:
Cov.:
32
AF XY:
AC XY:
637
AN XY:
74342
show subpopulations
African (AFR)
AF:
AC:
1295
AN:
41484
American (AMR)
AF:
AC:
57
AN:
15294
Ashkenazi Jewish (ASJ)
AF:
AC:
0
AN:
3466
East Asian (EAS)
AF:
AC:
0
AN:
5160
South Asian (SAS)
AF:
AC:
0
AN:
4818
European-Finnish (FIN)
AF:
AC:
0
AN:
10592
Middle Eastern (MID)
AF:
AC:
1
AN:
294
European-Non Finnish (NFE)
AF:
AC:
18
AN:
67938
Other (OTH)
AF:
AC:
14
AN:
2108
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.503
Heterozygous variant carriers
0
71
142
212
283
354
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance
Age Distribution
Genome Het
Genome Hom
Variant carriers
0
20
40
60
80
100
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
Alfa
AF:
Hom.:
Bravo
AF:
Asia WGS
AF:
AC:
14
AN:
3478
ClinVar
Not reported inComputational scores
Source:
Name
Calibrated prediction
Score
Prediction
BayesDel_noAF
Benign
DANN
Benign
PhyloP100
Splicing
Find out detailed SpliceAI scores and Pangolin per-transcript scores at
Publications
You must be logged in to view publications. This limit was set because tens of millions (!) of queries from AI bots are generated daily.